Alnylam Pharmaceuticals Inc. (ALNY)

$ 400.17
   
  • Change Today:
    $2.52
  • 52 Week High: $482.13
  • 52 Week Low: $222.98
  • Currency: US Dollars
  • Shares Issued: 106.30m
  • Volume: 22
  • Market Cap: $42,540m
  • RiskGrade: 247

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 5,364.01 1,048.09 582.12¢ 68.7 0.3 +272% n/a 0.0%
31-Dec-27 6,857.38 1,943.00 1,104.21¢ 36.2 0.4 +90% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

ALNY Market Data

Currency US Dollars
Share Price $ 400.17
Change Today $ 2.52
% Change 0.63 %
52 Week High $482.13
52 Week Low $222.98
Volume 22
Shares Issued 106.30m
Market Cap $42,540m
RiskGrade 247

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 7
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page